InChI=1S/C13H13N3.C4H6O6/c1-2-16-13-5-11-9-3-8(6-14-7-9)10(11)4-12(13)15-1;5-1(3(7)8)2(6)4(9)10/h1-2,4-5,8-9,14H,3,6-7H2;1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1 |
TWYFGYXQSYOKLK-LREBCSMRSA-N |
O[C@H]([C@@H](O)C(O)=O)C(O)=O.C1C2CNCC1c1cc3nccnc3cc21 |
|
nicotinic acetylcholine receptor agonist
An agonist that selectively binds to and activates a nicotinic acetylcholine receptor.
serotonergic agonist
An agent that has an affinity for serotonin receptors and is able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. Serotonin agonists are used as antidepressants, anxiolytics, and in the treatment of migraine disorders.
|
|
nicotinic acetylcholine receptor agonist
An agonist that selectively binds to and activates a nicotinic acetylcholine receptor.
serotonergic agonist
An agent that has an affinity for serotonin receptors and is able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. Serotonin agonists are used as antidepressants, anxiolytics, and in the treatment of migraine disorders.
|
|
View more via ChEBI Ontology
7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxalin-8-ium (2R,3R)-3-carboxy-2,3-dihydroxypropanoate
|
7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline (2R,3R)-2,3-dihydroxysuccinic acid
|
7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)(3)benzazepine (2R,3R)-2,3-dihydroxybutanedioate
|
ChemIDplus
|
CP 526555-18
|
ChemIDplus
|
CP-526,555-18
|
ChemIDplus
|
varenicline monotartrate
|
ChEBI
|
Champix
|
ChemIDplus
|
Chantix
|
KEGG DRUG
|
14347664
|
Reaxys Registry Number
|
Reaxys
|
375815-87-5
|
CAS Registry Number
|
ChemIDplus
|
375815-87-5
|
CAS Registry Number
|
KEGG DRUG
|
22993168
|
PubMed citation
|
Europe PMC
|
25013685
|
PubMed citation
|
Europe PMC
|
25031315
|
PubMed citation
|
Europe PMC
|
25545858
|
PubMed citation
|
Europe PMC
|
|